Stock Ratings / Health Care / SNWV / financials

SRTS (46) TELA (36) XTNT (69) MDAI (21) ⌘ Pro Terminal →

SANUWAVE Health Inc. (SNWV) Revenue-to-Profit Sankey Flow & SEC XBRL Financials

$5.27 0.00% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)

SANUWAVE Health Inc. (SNWV) carries a Roarable Rating of D+ (Sell) with 53/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D+ • SELL / AVOID Cap $45.3M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERSELL / AVOID • D+

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw C- · Rk D-

Each axis scored 0–20

12M PRICE TARGET CONE-2.3% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for SNWV)Realized 20D OHLCV Swing Band: ±12.5%

VISUAL REVENUE-TO-PROFIT SANKEY WATERFALL • FY 2025 (10-K)

How SNWV Turns Every Dollar of Sales Into Real Bottom-Line Profit

Free Cash Flow:$1.9M (4.4% FCF Margin)

Multi-Year SEC EDGAR XBRL Revenue, Net Profit & Free Cash Flow Trajectory

■ Revenue■ Net Profit■ Free Cash Flow

FY23

Rev $19.3M

FY24

Rev $32.3M

FY25

Rev $44.1M

Fiscal Year	Revenue	Gross Margin	Op Margin	Net Profit	Free Cash Flow	ROIC %
FY 2025	$44.1M	77.1%	11.2%	$11.8M	$1.9M	67.3%
FY 2024	$32.3M	75.9%	11.9%	-$33.1M	$2.0M	95%
FY 2023	$19.3M	77.1%	-2.8%	-$25.8M	-$4.5M	67.3%

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring SNWV)

✓Walkthrough of SNWV's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

SNWV // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -67.81%▲ RESISTANCE BREAKOUT

2026-10-30O $4.96H $5.27L $4.96C $5.27VOL 11.9K

RES: $4.42SUP: $2.02SMA50: $4.82SMA200: $13.49

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

SNWV Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 SNWV Butterfly Map → + Track SNWV →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

-15.0%/yr Implied 5Y Growth

vs. +36.3% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on SNWV today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for SNWV. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for SNWV today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (SNWV)

Health Care Rank #308 of 1016 ⚔️ SRTS vs SNWV Full Matrix →

1. Head-to-Head Health Care Peer Comparison (SNWV vs. SRTS, TELA, XTNT, MDAI)

Industry: Medical/Dental Instruments (120 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, SANUWAVE Health Inc. (SNWV) ranks #308 by composite RQD confidence (53/100, grade D+) and #764 by equity capitalization ($45.3M). Within this direct 5-issuer industry benchmark cohort, SNWV leads on earnings valuation at 3.8x trailing P/E, while SNWV leads on capital efficiency and profitability with 67.3% ROIC and 77.1% gross margin. XTNT currently holds the highest overall quantitative score in the immediate peer group at 69/100 (C+) compared with SNWV at 53/100 (D+).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
SNWV ACTIVE SANUWAVE Health Inc.	D+	53/100	3.8x	77.1%	67.3%	0.00%	$45.3M	Benchmark Subject
SRTS Sensus Healthcare Inc.	D	46/100	—	43.2%	-31.3%	-1.77%	$45.6M	/srts-vs-snwv →
TELA TELA Bio Inc.	D-	36/100	—	67.7%	-35.0%	-5.74%	$41.5M	/tela-vs-snwv →
XTNT Xtant Medical Holdings Inc.	C+	69/100	—	62.9%	12.8%	+1.54%	$40.7M	/xtnt-vs-snwv →
MDAI Spectral AI Inc. (Class A)	E	21/100	—	45.4%	-35.0%	+0.64%	$50.5M	/mdai-vs-snwv →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001417663

In its most recent audited fiscal period (FY2025, filed 2025-12-31), SANUWAVE Health Inc. (SNWV) reported GAAP revenue of $44.1M (+36.3% vs. FY2024 revenue of $32.3M , and +128.8% cumulative change since FY2023) , GAAP net income of $11.8M, operating cash flow of $3.9M, and free cash flow of $1.9M (-1.6% YoY). On the balance sheet, SNWV closed FY2025 with $37.3M in total assets against $16.1M in total debt (Altman Z-Score: N/A, Piotroski F-Score: 7/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$44.1M	$11.8M	$3.9M	$1.9M	$37.3M	$16.1M
FY2024 (FY)	2024-12-31	$32.3M	-$33.1M	$2.5M	$2.0M	$30.1M	—
FY2023 (FY)	2023-12-31	$19.3M	-$25.8M	-$4.5M	-$4.5M	—	—

3. SNWV Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is SNWV stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, SANUWAVE Health Inc. (NASDAQ: SNWV) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 53/100 at a spot price of $5.27 (0.00% 1D, market cap $45.3M). Pillar breakdown: Fundamental Cash Engine 11/20, Institutional 13F & Options Flow 7/20, Executive Insider Alignment 10/20, FRED Macro Regime Fit 7/20, and SEC Balance-Sheet Forensics 18/20. Across 1016 tracked Health Care issuers, SNWV ranks #308 in composite RQD confidence.

How does SNWV compare to SRTS and TELA in the Health Care sector?

Within the Health Care sector (Medical/Dental Instruments), SNWV carries a Roarable D+ (53/100 RQD), trailing P/E of 3.8x, gross margin of 77.1%, and ROIC of 67.3%. By comparison, SRTS (Sensus Healthcare Inc.) holds a D grade (46/100 RQD, P/E N/A, ROIC -31.3%, cap $45.6M) and TELA (TELA Bio Inc.) posts a D- grade (36/100 RQD, P/E N/A, ROIC -35.0%, cap $41.5M). Among the 5-stock peer group, SNWV leads on earnings multiple (3.8x) while SNWV leads on capital efficiency (67.3% ROIC).

What are the biggest fundamental strengths and SEC risk factors for SNWV?

Per SNWV's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001417663), SANUWAVE Health Inc. generated $44.1M in revenue (+36.3% YoY), $11.8M in net income, and $1.9M in free cash flow against $37.3M in total assets and $16.1M in total debt. Key quantitative strengths: Company leadership has skin in the game with net positive insider conviction.. Primary risk factors monitored: Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is SNWV trading relative to its 50-day, 200-day, and 52-week technical levels?

SNWV last traded at $5.27 (0.00% on volume of 14,696 shares), positioning the stock +9.34% above its 50-day simple moving average ($4.82) and -60.93% below its 200-day simple moving average ($13.49). Across its 52-week range of $3.92 to $36.20, SNWV sits at the 4.2% percentile with a 14-day RSI of 50.4 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($4.61 to $5.93).